Drawing for TRANSFORM ONCOLOGY CARE

USPTO serial 88673382

TRANSFORM ONCOLOGY CARE

Reviewed by CopyMark Law Group

Reg. 6521433Status 700Renewal
Filing date
Status date
Registration date
Oct 12, 2021
Examiner
HOLTZ, ALLISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRANSFORM ONCOLOGY CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

ONE CVS DRIVEMAILCODE: 1160WOONSOCKET, RI 02895

Goods and services

ClassDescriptionStatusFirst use
035Specialty pharmaceutical distributorship services, namely, distributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management services, namely, clinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; business administration of pharmacy reimbursement programs and services; Medical referrals; Managed care services, namely, electronic processing of health care and pharmaceutical information; Business management in the field of clinical trials, namely, providing information management servicesACTIVENov 1, 2019
036Insurance claims administration for medical claims and pharmaceuticals, processing of insurance claims and payment data; pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; financial administration of pharmacy reimbursement programs and servicesACTIVENov 1, 2019
044Providing health services, namely, personal health assessments and screenings; disease care management services; Medical services in the field of oncology, namely, prior authorization services, therapy and diagnostic services, and treatment support services; Nursing services; Therapeutic pharmaceutical services, namely, dispensing of pharmaceuticals and counseling on medications, incorporating disease monitoring services and clinical reviews; pharmaceutical advice; disease management programs; Medical services, namely, providing in-home and ambulatory infusion pharmacy services, and providing oncology servicesACTIVENov 1, 2019
045Specialty care management services, namely, providing case management services in the nature of coordinating medical care for persons with medical conditions requiring specialized careACTIVENov 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 12, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 4, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 26, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 24, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 20, 2021IUAFUSE AMENDMENT FILED—
Aug 20, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 22, 2021EX2GSOU EXTENSION 2 GRANTED—
Jul 22, 2021EXT2SOU EXTENSION 2 FILED—
Jul 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 20, 2021EX1GSOU EXTENSION 1 GRANTED—
Jan 20, 2021EXT1SOU EXTENSION 1 FILED—
Jan 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 4, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 9, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 20, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2019DOCKASSIGNED TO EXAMINER—
Nov 8, 2019TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 8, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance